Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tobramycin for Inhalation in Young Children With Cystic Fibrosis
NCT00006280Phase 2Completed
- Sponsor
- National Institute of Diabetes and Digestive and Kidney Diseases
- Start
- Feb 2000
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of tobramycin in cystic fibrosis (CF), sponsored by National Institute of Diabetes and Digestive and Kidney Diseases. Started Feb 2000; status: completed.
02
Drugs
tobramycin
03
Conditions
cystic fibrosis (CF)
Beyond the preview
Go deeper on NCT00006280.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00006280.